In the BioHarmony Drug Report Database

"Preview" Icon

Peginterferon beta-1a

Plegridy (peginterferon beta-1a) is a protein pharmaceutical. Peginterferon beta-1a was first approved as Plegridy on 2014-07-17. It is used to treat multiple sclerosis in the USA. It has been approved in Europe to treat multiple sclerosis.

 

Trade Name

 

Plegridy
 

Common Name

 

peginterferon beta-1a
 

ChEMBL ID

 

CHEMBL2108677
 

Indication

 

multiple sclerosis
 

Drug Class

 

Pegylated compounds

Image (chem structure or protein)

Peginterferon beta-1a structure rendering